Arcturus Therapeutics Holdings Inc. (ARCT)

ARCT Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	230.91	237.03	292.01	391.88	370.49
Cash & Short-Term Investments	230.91	237.03	292.01	391.88	370.49
Cash Growth	-2.58%	-18.83%	-25.49%	5.77%	-19.96%
Accounts Receivable	5.56	3.97	32.06	2.76	3.37
Other Current Assets	4.97	64.98	62.52	8.69	5.1
Total Current Assets	241.45	305.98	386.59	403.33	378.96
Net Property, Plant & Equipment	27.82	36.21	40.93	44.96	11.26
Long-Term Investments	-	-	-	-	0.52
Other Long-Term Assets	1.89	1.89	1.89	2.09	2.08
Total Assets	271.15	344.07	429.4	450.39	392.81
Accounts Payable	4.24	7.19	5.28	7.45	10.06
Accrued Expenses	23.9	38.78	31.88	30.23	23.52
Current Portion of Long-Term Debt	-	-	-	60.66	22.47
Unearned Revenue	8.25	19.51	44.83	28.65	43.48
Total Current Liabilities	36.38	65.49	81.99	126.98	99.54
Long-Term Debt	-	-	-	-	40.63
Long-Term Leases	20.78	25	25.91	30.22	4.5
Other Long-Term Liabilities	-	12.6	42.99	22.88	19.93
Total Long-Term Liabilities	20.78	37.6	68.9	53.09	65.07
Total Liabilities	57.16	103.09	150.89	180.08	164.6
Common Stock	0.03	0.03	0	0.03	0.03
Additional Paid-in Capital	728.55	689.76	646.35	608.43	575.68
Retained Earnings	-514.59	-448.81	-367.87	-338.14	-347.49
Shareholders' Equity	213.99	240.98	278.51	270.31	228.21
Total Liabilities & Equity	271.15	344.07	429.4	450.39	392.81
Total Debt	20.78	25	25.91	90.87	67.61
Net Cash (Debt)	210.13	212.03	266.1	301.01	302.88
Net Cash Growth	-0.90%	-20.32%	-11.60%	-0.62%	-31.75%
Net Cash Per Share	7.67	7.85	9.99	11.11	11.51
Book Value	213.99	240.98	278.51	270.31	228.21
Book Value Per Share	7.81	8.93	10.46	9.98	8.67
Tangible Book Value	213.99	240.98	278.51	270.31	228.21
Tangible Book Value Per Share	7.81	8.93	10.46	9.98	8.67

Updated Mar 3, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q